| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
2 companies
Heery Christopher is a Chief Medical Officer at Arcellx, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 11 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 3,000 | $43.44 | $130,329.26 | -10.4% | -21.4% | +22.6% | |
| Apr 24, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 20,000 | $40.00 | $800,068.00 | -63.1% | -15.5% | +35.4% | |
| Apr 19, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 21,642 | $35.01 | $757,660.83 | -44.8% | -4.0% | +54.6% | |
| Apr 3, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 3,000 | $30.71 | $92,120.65 | -8.7% | +7.3% | +119.2% | |
| Feb 9, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 6,966 | $30.77 | $214,333.37 | -30.9% | +54.2% | +113.3% | |
| Feb 3, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 1,255 | $35.11 | $44,068.07 | -100% | +32.3% | +94.3% | |
| Jan 3, 2023 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 2,500 | $31.11 | $77,775.00 | -100% | -5.3% | +75.5% | |
| Dec 13, 2022 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 12,500 | $30.03 | $375,320.00 | -100% | -12.3% | +60.5% | |
| Dec 19, 2019 | DTIL Precision Biosciences Inc | Chief Medical Officer | Buy | 2,485 | $12.08 | $30,021.30 | +994.0% | - | - |